US equities
|
MU
$1,046.38
▼-1.76%
NVDA
$230.31
▲+0.85%
SNDK
$1,726.45
▼-0.77%
TSLA
$358.35
▲+1.00%
INTC
$119.10
▼-0.94%
AMD
$609.41
▼-0.38%
GOOGL
$340.70
▼-0.98%
LITE
$1,071.68
▲+10.34%
MU
$1,046.38
▼-1.76%
NVDA
$230.31
▲+0.85%
SNDK
$1,726.45
▼-0.77%
TSLA
$358.35
▲+1.00%
INTC
$119.10
▼-0.94%
AMD
$609.41
▼-0.38%
GOOGL
$340.70
▼-0.98%
LITE
$1,071.68
▲+10.34%
FinancialContent
Watchlist
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
My watchlist
My portfolio
Recent quotes
Aptevo Therapeutics Inc. - Common Stock
(NQ:
APVO
)
1.810
-0.010 (-0.55%)
Delayed Quote
Updated: 11:16 AM EDT, Oct 1, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Aptevo Therapeutics Inc. - Common Stock
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Why Intel Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
↗
September 17, 2024
Via
Benzinga
Aptevo Therapeutics Announces $3.0 Million Offering Priced At-the-Market Under Nasdaq Rules
September 16, 2024
Via
ACCESSWIRE
Aptevo Therapeutics and Alligator Bioscience Announce Data from Phase 1 ALG.APV-527 Monotherapy Trial Showing 60% of Evaluable Patients Achieved Stable Disease in Solid Tumor Study
September 16, 2024
Via
ACCESSWIRE
Aptevo Therapeutics and Alligator Bioscience to Present Positive Interim Phase 1 Data Evaluating ALG.APV-527 Monotherapy in Multiple Solid Tumor Types, at ESMO Congress 2024
September 13, 2024
Via
ACCESSWIRE
Phase 1b/2 "RAINIER" Frontline Acute Myeloid Leukemia (AML) Trial Initiated
August 13, 2024
Via
ACCESSWIRE
Aptevo Therapeutics Presenting at The Protein & Antibody Engineering Summit, Boston, MA
May 14, 2024
Via
ACCESSWIRE
APVO Stock Earnings: Aptevo Therapeutics Beats EPS for Q2 2024
↗
August 08, 2024
APVO stock results show that Aptevo Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Aptevo Therapeutics Reports 2Q 2024 Financial Results and Provides a Business Update
August 08, 2024
Via
ACCESSWIRE
Why Domino's Pizza Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
July 18, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
↗
July 18, 2024
Pre-market stock movers are worth diving into this morning and we have all of the hottest news worth checking out on Thursday!
Via
InvestorPlace
Why Chuy's Holdings Shares Are Trading Higher By 47%; Here Are 20 Stocks Moving Premarket
↗
July 18, 2024
Via
Benzinga
Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
↗
July 17, 2024
Via
Benzinga
Why Bloom Energy Group Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
↗
July 17, 2024
Via
Benzinga
Aptevo Therapeutics Announces Closing of $2.75 Million Offering
July 01, 2024
Via
ACCESSWIRE
Aptevo Therapeutics Announces $2.75 Million Offering Priced At-the-Market Under Nasdaq Rules
June 28, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
June 17, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
↗
June 17, 2024
We have all of the biggest pre-market stock movers that investors are going to want to keep an eye on for Monday morning!
Via
InvestorPlace
Aptevo Participating in the BIO International Convention
June 03, 2024
Via
ACCESSWIRE
APVO Stock Earnings: Aptevo Therapeutics Beats EPS for Q1 2024
↗
May 08, 2024
APVO stock results show that Aptevo Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Aptevo Therapeutics Reports 1Q 2024 Financial Results and Provides a Business Update
May 08, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Friday's After-Market Session
↗
May 03, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
May 02, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
May 02, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
↗
May 02, 2024
Pre-market stock movers are worth checking out with our coverage of all the latest and greatest news happening on Thursday!
Via
InvestorPlace
Why Aspen Aerogels Shares Are Trading Higher By 26%; Here Are 20 Stocks Moving Premarket
↗
May 02, 2024
Via
Benzinga
Aptevo Therapeutics Announces Closing of $4.6 Million Public Offering
April 15, 2024
Via
ACCESSWIRE
Nasdaq Jumps 250 Points; Crude Oil Down 1%
↗
April 11, 2024
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite surging more than 250 points on Thursday. The Dow traded up 0.18% to 38,532.50 while the NASDAQ rose 1.63% to 16,433.83....
Via
Benzinga
Topics
Stocks
Why Aptevo Therapeutics Stock Is Cratering
↗
April 11, 2024
Aptevo announced the pricing of a public offering of 3,400,000 shares of its common stock or pre-funded warrants in lieu thereof and warrants to purchase up to an aggregate of 6,800,000 shares of its...
Via
Benzinga
Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
April 11, 2024
Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial results.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
April 11, 2024
Via
Benzinga
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
